Home » Stocks » AWH

Aspira Women's Health, Inc. (AWH)

Stock Price: $3.77 USD 0.13 (3.57%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed
After-hours: $3.84 +0.07 (1.86%) Oct 30, 4:45 PM

Stock Price Chart

Key Info

Market Cap 392.18M
Revenue (ttm) 4.56M
Net Income (ttm) -14.74M
Shares Out 104.03M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $3.77
Previous Close $3.64
Change ($) 0.13
Change (%) 3.57%
Day's Open 3.68
Day's Range 3.42 - 3.78
Day's Volume 532,610
52-Week Range 0.53 - 5.78

More Stats

Market Cap 392.18M
Enterprise Value 383.45M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 104.03M
Float 51.15M
EPS (basic) -0.16
EPS (diluted) -0.16
FCF / Share -0.14
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 9.92M
Short Ratio 14.16
Short % of Float 19.39%
Beta 3.19
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 86.02
PB Ratio 47.67
Revenue 4.56M
Operating Income -14.88M
Net Income -14.74M
Free Cash Flow -13.40M
Net Cash 8.73M
Net Cash / Share 0.08
Gross Margin 26.21%
Operating Margin -326.39%
Profit Margin -323.40%
FCF Margin -293.86%
ROA -59.53%
ROE -142.92%
ROIC 4,844.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

Current: $3.77
Target: 8.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth48.64%-2.18%18.13%21.36%-13.65%-1.75%22.54%8.89%63.66%-
Gross Profit1.20-0.090.21-0.06-
Operating Income-15.28-11.33-10.44-14.95-19.25-19.21-8.86-8.62-17.74-16.28
Net Income-15.24-11.37-10.50-14.97-19.12-19.21-8.82-7.15-17.79-19.03
Shares Outstanding86.6070.0956.9452.2047.1236.0820.9315.0114.2510.40
Earnings Per Share-0.18-0.16-0.20-0.29-0.41-0.53-0.42-0.48-1.25-1.83
Operating Cash Flow-12.97-9.37-8.13-13.96-18.37-16.81-8.22-10.40-15.58-20.94
Capital Expenditures-0.13-0.11-0.06-1.26-1.06-0.26-0.32-0.01-0.10-0.18
Free Cash Flow-13.10-9.48-8.19-15.22-19.42-17.07-8.55-10.41-15.68-21.11
Cash & Equivalents11.709.365.545.2418.6422.9729.508.0122.4822.91
Total Debt1.291.481.671.85-
Net Cash / Debt10.417.883.873.3918.6421.8628.406.9015.4810.91
Book Value8.747.153.413.7617.5519.2626.774.6710.364.62
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aspira Women's Health, Inc.
Country United States
Employees 52
CEO Valerie Barber Palmieri

Stock Information

Ticker Symbol AWH
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: AWH


Aspira Women's Health, together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. The company provides sells OVA1, Overa, and Ova1PLUS risk of malignancy tests for ovarian cancer. It also offers ASPiRA GenetiX, a genetic test for specific women's health diseases. In addition, the company owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, it is developing diagnostic algorithms, as well as a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. The company serves physicians, physician office laboratories, and hospital laboratories. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was founded in 1993 and is headquartered in Austin, Texas.